Human adjuvant-related syndrome or autoimmune/inflammatory syndrome induced by adjuvants. Where have we come from? Where are we going? A proposal for new diagnostic criteria

Lupus

Volumn 24, Issue 10, 2015, Pages 1012-1018

  Alijotas Reig, J ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Adjuvant; autoimmune inflammatory syndrome induced by adjuvants; autoimmunity; biomaterials; diagnostic criteria; granuloma; human adjuvant disease; Sj gren syndrome

Indexed keywords

ADJUVANT; AUTOANTIBODY; BIOMATERIAL; HLA ANTIGEN; IMMUNOLOGICAL ADJUVANT; PARAFFIN; SILICONE; VACCINE; PHARMACEUTICAL VEHICLES AND ADDITIVES; SILICONE DERIVATIVE;

AUTOIMMUNE DISEASE; AUTOIMMUNE DISEASE INDUCED BY ADJUVANTS; BREAST AUGMENTATION; CHRONIC FATIGUE SYNDROME; CONNECTIVE TISSUE DISEASE; FOREIGN BODY; GRANULOMA; HISTOPATHOLOGY; HLA SYSTEM; HUMAN; HUMAN ADJUVANT RELATED SYNDROME; IMMUNE SYSTEM; IMPLANT; INFLAMMATION; INFLAMMATORY DISEASE; LABORATORY; LABORATORY TEST; MACROPHAGIC MYOFASCIITIS SYNDROME; PERSIAN GULF SYNDROME; POST VACCINATION SYNDROME; PRIORITY JOURNAL; REVIEW; SENSITIZATION; SICK BUILDING SYNDROME; SJOEGREN SYNDROME; SYNDROME; SYNDROME DELINEATION; SYSTEMIC LUPUS ERYTHEMATOSUS; VACCINATION; VACCINATION REACTION; CHEMICALLY INDUCED; IMMUNOLOGY;

ADJUVANTS, IMMUNOLOGIC; ADJUVANTS, PHARMACEUTIC; AUTOIMMUNE DISEASES; BIOCOMPATIBLE MATERIALS; HUMANS; SILICONES; VACCINES;

EID: 84938819029     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203315579092     Document Type: Review

References (40)

1. Miyoshi K, Miyaoka T, Kobayashi Y,. Hypergammaglobulinemia by prolonged adjuvanticity in man: disorders developed after augmentation mammoplasty. Ijishimpo 1964; 22: 9-14.
2. Miyoshi K, Shiragami H, Yoshida K,. Adjuvant disease of man. Clin Immunol (Tokyo) 1973; 5: 532-537.
3. Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y,. Adjuvants and autoimmunity. Lupus 2009; 19: 1217-1225.
4. Shoenfeld Y, Agmon-Levin N,. 'ASIA' -Autoimmune/inflammatory Syndrome Induced by Adjuvants. J Autoimmun 2011; 36: 4-8.
5. Miró-Mur F, Hindié M, Kandhaya-Pillai R, Tobajas V, Schwartz JrS, Alijotas-Reig J,. Medical-grade silicone induces release of proinflammatory cytokines in peripheral blood mononuclear cells without activating T cells. J Biomed Mater Res Part B 2009; 90B: 510-520.
6. Alijotas-Reig J, Hindié M, Kandhaya-Pillai R, Miró-Mur F,. Bioengineered hyaluronic acid elicited a nonantigenic T cell activation: implications from cosmetic medicine and surgery to nanomedicine. J Biomed Mater Res A 2010; 95A: 180-190.
7. Roitt I, Brostoff J, Male D (eds) Inmunologia. Barcelona: Gower Medical Publishing Ltd, 1986.
8. Alijotas-Reig J, Garcia-Gimenez V,. Delayed immune-mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinical findings, long term follow-up and review of the literature. J Eur Acad Dermatol Venereol 2008; 22: 150-161.
9. Alijotas-Reig J, Garcia-Gimenez V, Miró-Mur F, Vilardell-Tarés M,. Delayed immune-mediated adverse effects of polyalkilimide dermal fillers. Arch Dermatol 2008; 144: 637-642.
10. Alijotas-Reig J,. Vasculits related to non-animal hyaluronic acid skin filler injections. Dermatol Surg 2010; 36: 272-273.
11. Hirsch RJ, Stier M,. Complications of soft tissue augmentation. J Drug Dermatol 2008; 7: 841-845.
12. Christensen L, Breiting V, Janssen M, Vuust J, Hogdall E,. Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg 2005; 29: 34-48.
13. Christen U, von Herrath G,. Infections and autoimmunity. Good or bad? J Immunol 2005; 174: 7481-7486.
14. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA,. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526-1533.
15. Rose NR,. Autoimmunity, infection and adjuvants. Lupus 2010; 19: 354-358.
16. Rsachi E, Borghi MO, Grossi C,. Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome. Lupus 2008; 17: 937-942.
17. Chen K, Huang J, Gong W,. Toll-like recptors in inflammation, infection and cancer. Int Immunopharmacol 2007; 26: 1271-1285.
18. Hormung V, Bauernfeind F, Halle A,. Silica crystals and aluminium salts mediate NALP-3 inflammasome activation via phagosomal destabilization. Nat Immunol 2008; 9: 847-856.
19. Brody GS, Conway DO, Deapen DM, Fisher JC, Hochberg MC, LeRoy EC,. Consensus statement on the relationship of breast implants to connective tissue disorders. Plast Reconstr Surg 1992; 90: 1102-1105.
20. Agmon-Levin N, Hughes GRV, Shoenfeld Y,. The spectrum of ASIA 'Autoimmune (auto-inflammatory) syndrome induced by adjuvants. Lupus 2012; 118: 20-20.
21. Soriano A,. The paradigm of ASIA (Autoimmune/inflammatry syndrome induced by adjuvants): A concept in evolution. IMAJ 2014; 16: 113-114.
22. Gherardi RK, Coquet M, Cherin P,. Macrophagic myofascitis lesions assess long-term persistence of vaccine-derived alumunium hydroxide in muscles. Brain 2001; 124: 1821-1831.
23. Eitan I, Agmon-Levin N, Blank M, Shoenfeld Y,. Adjuvants and immunity. Lupus 2009; 18: 1217-1225.
24. Tabuenca JM,. Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline. Lancet 1981; ii: 567-568.
25. Antó JM, Taylor AJ, Moya C,. Outbreak of organising pneumonia in textile printing sprayers. Collaborative Group for the Study of Toxicity in Textile Aerographic Factories. Lancet 1994; 344: 498-502.
26. Norback D,. An update on sick building syndrome. Curr Opin Allergy Clin Immunol 2009; 9: 55-59.
27. Israel E, Pardo A,. The sick building syndrome as a part of the autoimmune (auto-inflammatory) syndrome induced by adjuvants. Mod Rheumatol 2011; 21: 235-239.
28. Mosca M, Neri R, Bonbardieri S,. Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol 1999; 17: 585-589.
29. Mosca M, Baldini C, Bombardieri S,. Undifferentiated connective tissue diseases in 2004. Clin Exp Rheumatol 2004; 22 (Suppl. 33): S14-S18.
30. Amador-Patarroyo MJ, Arbelaez JG, Mantilla RD,. Sjogren's syndrome at the crossroad of polyautoimmunity. J Autoimmun 2012; 39: 199-205.
31. Peri Y, Agmon-Levin N, Theodor E, Shoenfeld Y,. Sjogren's syndrome, the old and the new. Best Pract Res Clin Rheumatol 2012; 26: 105-117.
32. Colafrancesco S, Perricone C, Priori R, Valesini G, Shoenfeld Y,. Sjögren's syndrome: another facet of the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). J Autoimmunity 2014; 51: 10-16.
33. Requena C, Izquierdo MJ, Navarro M, Martinez A, Vilata JJ, Botella R,. Adverse reactions to injectable aesthetic microimplants. Am J Dermapathol 2001; 23: 197-202.
34. Centers for Diseases Control and Prevention. Chronic Fatigue Syndrome case-definition. Available at: www.cdc.gov/cfs/case-definition/1994.html (accesed 5 July 2014).
35. Agmon-Levin N, Shoenfeld Y,. Chronic fatigue syndrome with autoantibodeis the-The result of an augmented adjuvant effect of hepatitis-B vaccine and silicone implant. Autoimmunity Rev 2008; 8: 52-55.
36. Meroni PL. Autoimmune/inflammatry syndrome induced by adjuvants (ASIA): old truths and new syndrome? J Autoimmun 36; 36: 1-3.
37. Varga V, Schumacher R, Jimenez SA,. Systemic sclerosis after augmentation mammoplasty with silicone implants. Ann Intern Med 1989; 11: 377-383.
38. Alijotas-Reig J, Fernández-Figueras MT, Puig L,. Inflammatory, immune-mediated adverse reactions related to soft tissue dermal fillers. Semin Arthritis Rheum 2013; 43: 241-258.
39. Bogdanos DP, Smyk DS, Invernizzi P,. Infectome: a platform to trace infectious triggers of autoimmunity. Autoimmun Rev 2013; 12: 726-740.
40. Dellwo A. Central sensitivity syndromes. A 'family' of related illnesses. Available at: http://chronicfatigue.about.cpm/Central-Sensitivity-Syndromes.htm (accesed 18 July 2014).